Tilray Brands (TLRY) Gains from Sales and Divestitures (2019 - 2025)
Tilray Brands (TLRY) reported Gains from Sales and Divestitures of $33276.0 for Q2 2025, down 72.97% on a YoY basis from $123113.0 in Q2 2024, and down 72.97% quarter-over-quarter from $123113.0 in Q2 2024.
Tilray Brands (TLRY) Gains from Sales and Divestitures (2019 - 2025) Analysis & Trends
Tilray Brands has reported Gains from Sales and Divestitures for 7 years, with the latest figure at $33276.0 in Q2 2025.
- For the quarter ending Q2 2025, Gains from Sales and Divestitures fell 72.97% year-over-year to $33276.0; the trailing twelve-month figure through May 2025 stood at $33276.0 (down 72.97% YoY), and the FY2025 full-year result was $33276.0, down 72.97% from the prior year.
- Gains from Sales and Divestitures for Q2 2025 stood at $33276.0, down from $123113.0 in the prior quarter.
- The five-year high for Gains from Sales and Divestitures was $1.9 million in Q2 2022, with the low at $33276.0 in Q2 2025.
- Historically, Gains from Sales and Divestitures has averaged $684344.2 across 5 years, with a median of $390419.0 in 2023.
- Annual changes were most pronounced in 2022 — Gains from Sales and Divestitures surged 85.71% — and 2023, when it sank 79.11%.
- Tilray Brands' Gains from Sales and Divestitures stood at $1.0 million in 2021, then surged by 85.71% to $1.9 million in 2022, then slumped by 79.11% to $390419.0 in 2023, then tumbled by 68.47% to $123113.0 in 2024, then sank by 72.97% to $33276.0 in 2025.
- The last three Gains from Sales and Divestitures figures came in at $33276.0 (Q2 2025), $123113.0 (Q2 2024), and $390419.0 (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Tilray Brands | - | - | 54.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2025 | 33,276.00 |
| May 31, 2025 | 33,276.00 |
| May 31, 2024 | 123,113.00 |
| May 31, 2024 | 123,113.00 |
| May 31, 2023 | 390,419.00 |
| May 31, 2023 | 390,419.00 |
| May 31, 2022 | 1.87 Mn |
| May 31, 2022 | 1.87 Mn |
| May 31, 2021 | 1.01 Mn |
| May 31, 2021 | 1.01 Mn |
| Mar 31, 2020 | 53,125.00 |
| Mar 31, 2020 | 53,125.00 |
| Dec 31, 2019 | 122,289.00 |
| Dec 31, 2019 | 122,289.00 |
| Sep 30, 2019 | 54,635.00 |
| Sep 30, 2019 | 54,635.00 |